American Herbal Products Association (AHPA) > News > Alerts

AHPA Alerts

Subscribe >>

AHPA Adopts Policy Against Sale of Bulk Caffeine

Recent reports associate serious injury and death with use of pure caffeine purchased by consumers in bulk packaging.

The American Herbal Products Association (AHPA) Board of Trustees on March 4 established a trade requirement that prohibits sale by AHPA members of pure caffeine in bulk form at retail (to consumers).

Whitepaper on DNA barcode testing reveals how misapplication of science led to baseless results

The Capabilities and Limitations of DNA Barcode Testing

A comprehensive analysis of DNA barcode testing on botanical dietary supplements has called conclusions reached by the New York Attorney General’s (NY AG) office in an investigation of four major retailers of botanical supplements, a “…misuse of the technologies” that led to a “…misinterpretation of test results.”

AHPA responds to dozens of media outlets' coverage of New York Attorney General's inadequate testing of herbal supplements

AHPA has responded to more than 20 media outlets' coverage of the New York State Attorney General's supplement investigation to stress that the allegations are based on inadequate and unproven testing of herbal supplement products. The test results are at the core of the Attorney General's misinformed allegations that several major retailers are selling adulterated and/or mislabeled herbal dietary supplements. 

Contract Manufacturers and their Customers: Best Practices for Effective Partnerships

Presented November 13, 2014

Dietary supplement contract manufacturers and their “own-label distributor” customers must navigate a host of issues in order to establish effective business partnerships that ensure quality and compliance with federal laws and regulations

AHPA issues cannabis oversight recommendations for regulators

Oversight framework promotes best practices for cannabis production and distribution from seed to consumption

The American Herbal Products Association (AHPA) has published recommendations for regulators to address issues related to the safe use and responsible commerce of legally-marketed products derived from Cannabis species.

Federal judge approves consent decree with New York dietary supplement maker (FDA)

A federal judge in New York has signed a consent decree for permanent injunction between the United States and Mira Health Products Ltd., a dietary supplement manufacturer located in Farmingdale, New York, and Michael S. Ragno and Michael S. Ragno, Jr.

BMJ corrects column on MHRA's "traditional herbal registration" (BMJ)

FDA Inspections & Emerging cGMP Compliance Issues

Presented May 15, 2014

Tips for handling every aspect of a Food and Drug Administration (FDA) inspection--from pre-inspection preparation to interacting with on-site inspectors--and how to respond to observations and warning letters

L'Oréal settles FTC charges alleging deceptive advertising for anti-aging cosmetics (FTC)

Cosmetics company L'Oréal USA, Inc. has agreed to settle Federal Trade Commission charges of deceptive advertisingabout its Lancôme Génifique and L'Oréal Paris Youth Code skincare products. According to the FTC's complaint, L'Oréal made false and unsubstantiated claims that its Génifique and Youth Code products provided anti-aging benefits by targeting users' genes.

Producer of drug-spiked products masquerading as dietary supplements sentenced in federal court (FDA)

Nikki Haskell, the owner and chief executive officer of Balanced Health Products (BHP), has been sentenced by a United States magistrate judge in Manhattan federal court to a $60,000 fine for distributing dietary supplements that contained a prescription drug.
RSS
First 567891011121314

 Looking for Something?

 Click on these links to see a filtered list of alerts in one of these four topic areas

 

 


2017 Annual Fund Sponsors

           

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.